FDA authorises new use of test to identify the emerging pathogen Candida auris
The FDA has authorised the first test to identify the emerging pathogen Candida auris, which can cause serious infections in hospitalised patients...
List view / Grid view
The FDA has authorised the first test to identify the emerging pathogen Candida auris, which can cause serious infections in hospitalised patients...
Scientists report that by combining a robotic arm and mass spectrometry can potentially open up new branches of pharmaceutics...
Nitroproston is a novel prostaglandin-based compound with potential application in obstructive respiratory diseases...
Brazilian researchers combine mass spectrometry, 2-D liquid chromatography and ion mobility to identify over 10,000 proteins in brain cells possibly involved in schizophrenia.
Researchers at Vanderbilt University Medical Center have used an integrated imaging approach to probe an invasive Staphylococcus aureus (‘staph’) infection in a mouse model, revealing new insights about staph infections that can be broadly applied to other diseases.
Waters Corporation (NYSE:WAT) today introduced BioResolve™ RP mAb Polyphenyl 450 angstrom 2.7 micron solid core Columns intended for the reversed-phase analysis of intact or sub-unit-digested monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs) using LC-UV and LC-MS...
This In-Depth Focus looks at the benefits of mass spectrometry for the characterisation of protein higher order structure and for stability testing.
In this issue: DNA microarray for detecting, identifying and determining antimicrobial-resistant bacteria; the advantages of single-use technology and a framework for an implementation strategy; risk management when designing chemical safety assessments for pharmaceutical packaging systems.
Mass spectrometry is an extremely sensitive method for the detection and identification of traces of gaseous substances. The technique can quantify atoms or molecules and provide chemical and structural information (functional groups and side chains) on the compounds analysed...
Scientists have developed and validated a blood test for Alzheimer’s disease, with the potential to massively ramp up the pace of Alzheimer’s disease drug trials...
Researchers have systematically analysed and quantified the interactions of all proteins with metabolites on the level of the whole proteome...
Much rests on the further development of bioanalytical technologies which allow the highest level of sensitivity on small samples, and robust, high reproducibility across large populations. Johan Devenyns, CEO PharmaFluidics, explains further...
When thinking about the future of the pharmaceutical sector, it can be difficult to pinpoint a specific focus as there are a wide range of challenges that come into consideration across all stages of development and manufacturing. Dr Lynne Murdoch, Business Manager – Microbiology, Wickham Laboratories, considers some key points....
Method transfer or method scaling across different instrument platforms can be affected by both dwell volume and extra-column dispersion...
Researchers have developed a new drug screening technique that could lead to the rapid and accurate identification of drugs...